HATTERAS VENTURE PARTNERS
HATTERAS VENTURE PARTNERS is a Pre-seed, Seed and Series A fund in the US, Switzerland and China writing $500K–$20M checks into Healthcare, biopharmaceuticals, medical-devices, diagnostics and healthcare-it.
- Stages
- Pre-seed, Seed, Series A
- Sectors
- Healthcare, biopharmaceuticals, medical-devices, diagnostics, healthcare-it
- Check size
- $500K–$20M
- Invests in
- US-wide, Switzerland, China
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2000
- Assets under management
- 900M+
Thesis
Hatteras Venture Partners is a venture capital firm founded in 2000, headquartered in Durham, North Carolina. They focus on seed and early-stage companies in the life sciences and healthcare sectors, with a particular emphasis on biopharmaceuticals, medical devices, diagnostics, and healthcare IT. Their investment thesis centers on building transformative companies that advance human medicine through innovative therapies and disruptive technologies. Hatteras actively seeks opportunities with high scientific differentiation and the potential for significant impact on patient care, often investing in research-driven but undercapitalized regions, especially North Carolina and the Southeastern United States. The firm's strategy includes providing capital, strategic guidance, operational expertise, and access to a broad healthcare network, acting as a lead investor and engaging at the board level. As of August 2025, they manage over $900 million in capital across seven funds, with recent closings of two new funds totaling over $200 million. Their typical check size ranges from $500,000 to $5 million, with potential for larger investments up to $20 million.
Common questions
Does HATTERAS VENTURE PARTNERS invest at the Pre-seed stage?
Yes. HATTERAS VENTURE PARTNERS lists Pre-seed, Seed and Series A among the stages it invests in.
What check size does HATTERAS VENTURE PARTNERS write?
HATTERAS VENTURE PARTNERS writes $500K–$20M checks.
Where does HATTERAS VENTURE PARTNERS invest?
HATTERAS VENTURE PARTNERS invests in the US, Switzerland and China.